Increased Prevalence of Atopic Dermatitis in Children Aged 0-3 Years Highly Exposed to Parabens.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
06 11 2021
Historique:
received: 29 08 2021
revised: 26 10 2021
accepted: 01 11 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 19 11 2021
Statut: epublish

Résumé

The prevalence of allergic diseases, such as bronchial asthma, atopic dermatitis, nasal allergies (pollinosis), and food allergies, has been increasing in many countries. The hygiene hypothesis was recently considered from the perspective of exposure to antimicrobial agents and preservatives, such as parabens (CAS number, 94-13-3). It currently remains unclear whether parabens, which are included in many daily consumer products such as cosmetics, shampoos, and personal care products as preservative antimicrobial agents, induce or aggravate allergies. Therefore, the aim of the present study was to examine the relationship between exposure to parabens and the prevalence of allergic diseases in Japanese children. The cross-sectional epidemiology of 236 children aged 0-3 years who underwent health examinations in Shika town in Japan assessed individual exposure to parabens using urinary concentrations of parabens. The results obtained showed that the prevalence of atopic dermatitis was significantly higher in children with high urinary concentrations of parabens than in those with low concentrations (

Identifiants

pubmed: 34770171
pii: ijerph182111657
doi: 10.3390/ijerph182111657
pmc: PMC8583381
pii:
doi:

Substances chimiques

Parabens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Chemosphere. 2018 Jun;201:13-19
pubmed: 29510318
J Allergy Clin Immunol. 2012 Aug;130(2):453-60.e7
pubmed: 22704536
Int J Pediatr Otorhinolaryngol. 2013 Jul;77(7):1065-71
pubmed: 23701898
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):664-671
pubmed: 27896884
Allergy. 2021 Oct;76(10):3122-3132
pubmed: 33934374
Skin Therapy Lett. 2013 Jul-Aug;18(5):5-7
pubmed: 24305662
J Toxicol Environ Health B Crit Rev. 2017;20(2):104-117
pubmed: 28339349
Allergy Asthma Proc. 2014 Nov-Dec;35(6):475-81
pubmed: 25584915
Allergy. 2017 Nov;72(11):1768-1777
pubmed: 28281298
Curr Environ Health Rep. 2019 Dec;6(4):214-224
pubmed: 31745828
Int J Environ Health Res. 2020 Jul 31;:1-17
pubmed: 32735138
Int J Hyg Environ Health. 2021 Jul;236:113781
pubmed: 34119851
Asia Pac Allergy. 2019 Jan 21;9(1):e5
pubmed: 30740353
J Allergy Clin Immunol. 2019 Mar;143(3):948-956.e4
pubmed: 30194988
Nat Commun. 2020 Feb 11;11(1):561
pubmed: 32047148
J Nippon Med Sch. 2017;84(1):2-11
pubmed: 28331140
Environ Res. 2021 Mar;194:110502
pubmed: 33221310
Environ Pollut. 2017 Mar;222:307-314
pubmed: 28034559
Environ Int. 2018 Dec;121(Pt 1):538-549
pubmed: 30293015
Sci Rep. 2021 Feb 12;11(1):3772
pubmed: 33580129
Allergy. 2013 Jan;68(1):84-91
pubmed: 23146048
Environ Health. 2021 Jul 13;20(1):81
pubmed: 34256787
Biomed Res Int. 2019 Apr 21;2019:2450605
pubmed: 31119157
Environ Health Perspect. 2011 Mar;119(3):390-6
pubmed: 21062687
Environ Sci Technol. 2017 Apr 4;51(7):4009-4017
pubmed: 28318231
J Allergy Clin Immunol. 2018 Jul;142(1):269-278.e15
pubmed: 29111213
Environ Int. 2014 Jun;67:27-42
pubmed: 24657492
J Microbiol Immunol Infect. 2013 Oct;46(5):320-9
pubmed: 23751771
Sci Total Environ. 2020 Apr 15;713:135116
pubmed: 32019002

Auteurs

Johichi Arafune (J)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Hiromasa Tsujiguchi (H)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.
Advanced Preventive Medical Center, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Akinori Hara (A)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.
Advanced Preventive Medical Center, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Yukari Shimizu (Y)

Department of Nursing, Faculty of Health Sciences, Komatsu University, 14-1 Mukaimotorimachi, Komatsu 923-0961, Ishikawa, Japan.

Daisuke Hori (D)

Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

Thao Thi Thu Nguyen (TTT)

Faculty of Public Health, Haiphong University of Medicine and Pharmacy, Hai Phong 180000, Ngo Quyen, Vietnam.

Fumihiko Suzuki (F)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Toshio Hamagishi (T)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Yohei Yamada (Y)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Haruki Nakamura (H)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Takahiro Yoshikawa (T)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Koichiro Hayashi (K)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Aki Shibata (A)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Yuma Fukutomi (Y)

Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara 252-0392, Kanagawa, Japan.

Yukihiro Ohya (Y)

Allergy Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.

Kiwako Yamamoto-Hanada (K)

Allergy Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.

Go Muto (G)

Department of Hygiene, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara 252-0374, Kanagawa, Japan.
Center for Preventive Medical Science, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8670, Japan.

Ryoji Hirota (R)

The Graduate School of Health Science, Matsumoto University, 2095-1 Niimura, Matsumoto 390-1295, Nagano, Japan.

Tadashi Konoshita (T)

Third Department of Internal Medicine, University of Fukui Faculty of Medical Sciences, 23-3 Mat-suoka- Shimoaizaki, Eiheiji 910-1193, Fukui, Japan.

Yasuhiro Kambayashi (Y)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.
Department of Public Health, Faculty of Veterinary Medicine, Okayama University of Science, 1-3 Ikoinooka, Imabari 794-8555, Ehime, Japan.

Hiroyuki Nakamura (H)

Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.
Advanced Preventive Medical Center, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Ishikawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH